Louis Chen

Stock Analyst at Cantor Fitzgerald

(0.89)

# 2,882

Out of 4,496 analysts

6

Total ratings

50%

Success rate

-22.31%

Average return

Main Sectors:

Top Industries:

Medical Devices Biotechnology

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CATX Perspective Therapeutics	Reiterates: Overweight	n/a	$12.64	-	4	Jun 25, 2024
	THTX Theratechnologies	Reiterates: Overweight	$36	$1.56	+2,207.69%	2	Jul 13, 2023

Perspective Therapeutics

Jun 25, 2024

Reiterates: Overweight

Price Target: n/a

Current: $12.64

Upside: -

Theratechnologies

Jul 13, 2023

Reiterates: Overweight

Price Target: $36

Current: $1.56

Upside: +2,207.69%